Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
General Counsel
-
Issuer Symbol
-
SYRE on Nasdaq
There are no Buy or Sell transactions made by James Paul Kastenmayer since 14 Jan 2025
| Security |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
4,000 |
$2,243 |
$0.5608 |
23 Aug 2022 |
Direct |
|
|
| Employee Stock Option (right to buy) |
500,000 |
|
|
23 Feb 2023 |
Direct |
Common Stock |
|
Transactions reported by James Paul Kastenmayer for Spyre Therapeutics, Inc.
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.